Literature DB >> 26559376

Serous Neoplasms of the Pancreas: A Clinicopathologic Analysis of 193 Cases and Literature Review With New Insights on Macrocystic and Solid Variants and Critical Reappraisal of So-called "Serous Cystadenocarcinoma".

Michelle D Reid1, Hye-Jeong Choi, Bahar Memis, Alyssa M Krasinskas, Kee-Taek Jang, Gizem Akkas, Shishir K Maithel, Juan M Sarmiento, David A Kooby, Olca Basturk, Volkan Adsay.   

Abstract

The literature on "variants" and "malignant" counterparts of pancreatic serous cystic neoplasms (SCNs) is highly conflicted. Clinicopathologic characteristics of 193 SCNs were investigated, along with a critical literature review. For the macrocystic (oligocystic) variant, in this largest series, a demographic profile in contrast to current literature was elucidated, with 21% frequency, predominance in female individuals (4:1), body/tail location (1.7×), younger age of patients (mean age, 50 y), and frequent radiologic misdiagnosis as other megacystic neoplasms. Solid SCNs were rare (n=4, 2%) and often misinterpreted radiologically as neuroendocrine tumors. Available fine-needle aspiration in 11 cases was diagnostic in only 1. Radiologic impression was "malignancy" in 5%. Associated secondary tumors were detected in 13% of resections, mostly neuroendocrine. Secondary "infiltration" (direct adhesion/penetration) of spleen, stomach, colon, and/or adjacent nodes was seen in 6 (3%) fairly large SCNs (mean, 11 cm) with no distant metastasis. Three SCNs recurred locally, but completeness of original resection could not be verified. Our only hepatic SCN lacked a concurrent pancreatic tumor. Literature appraisal revealed that there are virtually no deaths that are directly attributable to dissemination/malignant behavior of SCNs, and most cases reported as "malignant" in fact would no longer fulfill the more recent World Health Organization criteria but instead would represent either (1) local adhesion/persistence of tumor, (2) cases with no histologic verification of malignancy, or (3) liver SCNs with benevolent behavior (likely representing multifocality, rather than true metastasis, especially considering there was no fatality related to this and no reported metastases to other remote sites). In conclusion, in contrast to the literature, the clinicopathologic characteristics of solid and macrocystic SCN variants are similar to their microcystic counterpart, although their radiologic diagnosis is challenging. Recurrence/secondary invasion of neighboring organs occurs rarely in larger SCNs but seems innocuous. An SCN should not be classified as "malignant" unless there is clear-cut evidence of histologic malignancy or documented distant metastasis.

Entities:  

Mesh:

Year:  2015        PMID: 26559376     DOI: 10.1097/PAS.0000000000000559

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  12 in total

Review 1.  Benign Tumors and Tumorlike Lesions of the Pancreas.

Authors:  Olca Basturk; Gokce Askan
Journal:  Surg Pathol Clin       Date:  2016-12

Review 2.  [Cystic lesions of the pancreas : Differential diagnostics and treatment].

Authors:  J Rosendahl; P Michl
Journal:  Internist (Berl)       Date:  2019-03       Impact factor: 0.743

Review 3.  Current perspectives on pancreatic serous cystic neoplasms: Diagnosis, management and beyond.

Authors:  Xiao-Peng Zhang; Zhong-Xun Yu; Yu-Pei Zhao; Meng-Hua Dai
Journal:  World J Gastrointest Surg       Date:  2016-03-27

Review 4.  Pancreatic Cystic Neoplasms: Different Types, Different Management, New Guidelines.

Authors:  Lianne Scholten; Nadine C M van Huijgevoort; Jeanin E van Hooft; Marc G Besselink; Marco Del Chiaro
Journal:  Visc Med       Date:  2018-06-08

5.  Pancreatic neuroendocrine tumor with complete replacement of the pancreas by serous cystic neoplasms in a patient with von Hippel-Lindau disease: a case report.

Authors:  Shimpei Maeda; Fuyuhiko Motoi; Shuhei Oana; Kyohei Ariake; Masamichi Mizuma; Takanori Morikawa; Hiroki Hayashi; Kei Nakagawa; Takashi Kamei; Takeshi Naitoh; Michiaki Unno
Journal:  Surg Case Rep       Date:  2017-09-25

6.  European evidence-based guidelines on pancreatic cystic neoplasms.

Authors: 
Journal:  Gut       Date:  2018-03-24       Impact factor: 23.059

7.  Serous cystadenoma of pancreas: A clinicopathologic experience of 23 cases from a major tertiary care center.

Authors:  Muhammad Usman Tariq; Zubair Ahmad; Jamshid Abdul-Ghafar; Nasir Ud Din
Journal:  Rare Tumors       Date:  2018-11-05

8.  Pseudo solid-appearing pancreatic serous microcystic adenomas: Histologic diagnosis with the EUS core biopsy fork-tip needle.

Authors:  Erminia Manfrin; Claudia Perini; Serena Di Stefano; Laura Bernardoni; Alice Parisi; Luca Frulloni; Sokol Sina; Andrea Remo; Armando Gabbrielli; Stefano Francesco Crinò
Journal:  Endosc Ultrasound       Date:  2019 Sep-Oct       Impact factor: 5.628

9.  Serous Microcystic Cystadenocarcinoma of the Pancreas with Synchronous Liver Metastases: Clinical Characteristics and Management.

Authors:  Dimitrios Massaras; Eirini V Pantiora; John Koutalas; Elias C Primetis; Georgios P Fragulidis
Journal:  Cureus       Date:  2020-04-17

Review 10.  Serous pancreatic neoplasia, data and review.

Authors:  Christoph F Dietrich; Yi Dong; Christian Jenssen; Valentina Ciaravino; Michael Hocke; Wen-Ping Wang; Eike Burmester; Kathleen Moeller; Nathan Ss Atkinson; Paola Capelli; Mirko D'Onofrio
Journal:  World J Gastroenterol       Date:  2017-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.